Lean Life Science - ODP2 Briefing Calls

ODP2 will give the next big UK-based breakthroughs in oncology access to bespoke expert scientific review, clinical study design, technical gap analysis, financial / business value modelling and integrated project planning.

Lean Life Science is delivering ODP2 in collaboration with four of the top ten global pharma companies, Cancer Research UK’s Cancer Research Horizons, Manchester Cancer Research Centre (MCRC) and over 20 specialist contract research organisations.

ODP2 is the flagship Oncology Development Programme from Lean Life Science aiming to identify, de-risk and catalyse commercially viable UK-based oncology innovations to improve diagnosis and treatment of cancer and accelerate the translation of emerging cancer research for patient benefit.

Please see available dates for our briefing calls below.

ODP2 will give the next big UK-based breakthroughs in oncology access to bespoke expert scientific review, clinical study design, technical gap analysis, financial / business value modelling and integrated project planning.

Lean Life Science is delivering ODP2 in collaboration with four of the top ten global pharma companies, Cancer Research UK’s Cancer Research Horizons, Manchester Cancer Research Centre (MCRC) and over 20 specialist contract research organisations.

ODP2 is the flagship Oncology Development Programme from Lean Life Science aiming to identify, de-risk and catalyse commercially viable UK-based oncology innovations to improve diagnosis and treatment of cancer and accelerate the translation of emerging cancer research for patient benefit.

Please see available dates for our briefing calls below.

Events

Sorry, there are no upcoming events